Using real-world claims data for planning oncology clinical trials
نویسندگان
چکیده
منابع مشابه
Using real-time alerts for clinical trials
E. Chow1; M. Zuberi2,3; R. Seto2; S. Hota6,7; E.N. Fish8,9 ; D. Morra1,4,5 1 Centre for Innovation in Complex Care, University Health Network; 2 Investigational Pharmacy Services, Department of Pharmacy Services, University Health Network; 3 Leslie Dan Faculty of Pharmacy, University of Toronto; 4 Department of Medicine, University of Toronto; 5 Centre for Interprofessional Education, Universit...
متن کاملClinical trials for precision oncology using next-generation sequencing
Large tumor sequencing studies have demonstrated that human cancers of a given histologic type are often heterogeneous with regard to the mutations that drive their invasion and that the mutations present in individual tumors have major influences on the natural history of the tumor, and its responsiveness to therapy. These findings are having a major impact on the development and evaluation of...
متن کاملReal-world applications: Motion planning using GAs
The environment in which the vehicle must move is often very complex. Furthermore, the vehicle itself may be a complex structure or possess a large degree of exibility. To simplify the detection of collisions, the real-world space is mapped to con guration space. Each dimension in this corresponds to one of the vehicle's degrees of freedom (eg. two spatial and one rotational). In con guration s...
متن کاملOntario protocol assessment level: clinical trial complexity rating tool for workload planning in oncology clinical trials.
PURPOSE The Ontario Institute for Cancer Research supported the creation of a working group with the objective of developing a standard rating scale to evaluate clinical trial complexity and applying the scale to facilitate workload measurement for Ontario cancer research sites. METHODS The lack of a mechanism to measure the workload involved in a clinical trials protocol was identified and c...
متن کاملMolecular imaging biomarkers for oncology clinical trials.
Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This "Focus on Molecular Imaging" article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2013
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.289